Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content

Studies have indicated that increasing plasma bilirubin levels might be useful for preventing and treating hepatic lipid accumulation that occurs with metabolic diseases such as obesity and diabetes. We have previously demonstrated that mice with hyperbilirubinemia had significantly less lipid accum...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipp, Zachary A., Martinez, Genesee J., Bates, Evelyn A., Maharramov, Agil B., Flight, Robert M., Moseley, Hunter N. B., Morris, Andrew J., Stec, David E., Hinds, Terry D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965094/
https://www.ncbi.nlm.nih.gov/pubmed/36837834
http://dx.doi.org/10.3390/metabo13020215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965094/
https://www.ncbi.nlm.nih.gov/pubmed/36837834
http://dx.doi.org/10.3390/metabo13020215

Ejemplares similares